Functional analysis of the human complement receptor 2 (CR2/CD21) promoter: Characterization of basal transcriptional mechanisms

被引:21
|
作者
Ulgiati, D
Pham, C
Holers, VM
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Dept Immunol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Dept Med, Denver, CO 80262 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
来源
JOURNAL OF IMMUNOLOGY | 2002年 / 168卷 / 12期
关键词
D O I
10.4049/jimmunol.168.12.6279
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human complement receptor (CR) type 2 (CR2/CD21) is a 145-kDa membrane protein encoded within the regulators of complement activation gene cluster localized on human chromosome 1q32. Understanding the mechanisms that regulate CR2 expression is important because CR2 is expressed during specific stages of B cell development, and several lines of evidence suggest a role for altered CR2 function or expression in a number of autoimmune diseases. Additionally, even modest changes in CR2 expression are likely to affect relative B cell responses. In this study we have delineated the transcriptional requirements of the human CR2 gene. We have studied the human CR2 proximal promoter and identified sites important for controlling the level of transcription in CR2-expressing cells. We have determined that four functionally relevant sites lie within very close proximity to the transcriptional initiation site. These sites bind the transcription factors USF1, an AP-2-like transcription factor, and Sp1.
引用
收藏
页码:6279 / 6285
页数:7
相关论文
共 50 条
  • [1] A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation
    Makar, KW
    Ulgiati, D
    Hagman, J
    Holers, VM
    INTERNATIONAL IMMUNOLOGY, 2001, 13 (05) : 657 - 664
  • [2] Transcriptional regulation of human CR2/CD21 gene expression
    Makar, KW
    Holers, VM
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 355 - 355
  • [3] Development of in vivo models for studying the transcriptional regulation of human complement receptor 2 (CR2/CD21): importance of chromatin accessibility
    Cruikshank, MN
    Goldie, LC
    Holers, VM
    Abraham, LJ
    Ulgiati, D
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 224 - 224
  • [4] ANALYSIS OF EPITOPE EXPRESSION AND THE FUNCTIONAL REPERTOIRE OF RECOMBINANT COMPLEMENT RECEPTOR-2 (CR2/CD21) IN MOUSE AND HUMAN-CELLS
    CAREL, JC
    FRAZIER, B
    LEY, TJ
    HOLERS, VM
    JOURNAL OF IMMUNOLOGY, 1989, 143 (03): : 923 - 930
  • [5] The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21)
    Hannan, Jonathan Paul
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2016, 17 (05) : 463 - 487
  • [6] Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-α:: A potential role in systemic lupus erythematosus
    Asokan, Rengasamy
    Hua, Jing
    Young, Kendra A.
    Gould, Hannah J.
    Hannan, Jonathan P.
    Kraus, Damian M.
    Szakonyi, Gerda
    Grundy, Gabrielle J.
    Chen, Xiaojiang S.
    Crow, Mary K.
    Holers, V. Michael
    JOURNAL OF IMMUNOLOGY, 2006, 177 (01): : 383 - 394
  • [7] Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function
    Marchbank, KJ
    Watson, CC
    Ritsema, DF
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 2000, 165 (05): : 2354 - 2361
  • [8] Transcriptional effects of a lupus-associated polymorphism in the 5′ untranslated region (UTR) of human complement receptor 2 (CR2/CD21)
    Cruickshank, Mark N.
    Karimi, Mahdad
    Mason, Rhonda L.
    Fenwick, Emily
    Mercer, Tim
    Tsao, Betty P.
    Boackle, Susan A.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2012, 52 (3-4) : 165 - 173
  • [9] C3 regulates expression of human complement receptor 2 (CR2, CD21) on mouse B cells
    Marchbank, KJ
    Kulik, L
    Birrell, L
    Haluzcszak, C
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 272 - 272
  • [10] The role of soluble complement receptor type 2 (CR2/CD21) in immune evasion of Candida albicans
    Buhlmann, D.
    Eberhardt, H. U.
    Prodinger, W. M.
    Skerka, C.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 312 - 313